Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Morel
Y
Y
INSERM Unit 329, Université de Lyon, France.
Miller
W L
WL
D019326:17-alpha-Hydroxyprogesterone; D000311:Adrenal Glands / Q000378:metabolism; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000737:chemistry; D015139:Blotting, Southern; D002784:Cholesterol / Q000096:biosynthesis; D002874:Chromosome Mapping; D002896:Chromosomes, Human, Pair 6; D003181:Complement C4 / Q000235:genetics; D003577:Cytochrome P-450 Enzyme System / Q000502:physiology; D003907:Dexamethasone / Q000627:therapeutic use; D005785:Gene Conversion; D006680:HLA Antigens / Q000235:genetics; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood; D009154:Mutation; D010641:Phenotype; D013255:Steroid 21-Hydroxylase / Q000235:genetics
D003181:Complement C4; D006680:HLA Antigens; D006908:Hydroxyprogesterones; D019326:17-alpha-Hydroxyprogesterone; D003907:Dexamethasone; D003577:Cytochrome P-450 Enzyme System; D002784:Cholesterol; D013255:Steroid 21-Hydroxylase